glp-1 binge eating Medications and Disordered Eating: A Personalized, Evidence-Based Approach GLP-1 for Binge Eating Disorder:

Hurych J, Oscarsson E, Hkanson et al (2023) Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the single-cell fecal parasitome in children with celiac disease autoimmunity: a randomized, double-blind placebo-controlled clinical trial

Individual results vary.

Alongside promoting weight loss, GLP-1 receptor agonists deliver key therapeutic benefits for patients with type 2 diabetes

Tracking symptom severity, distribution, and functional impact on a consistent schedule reveals trends that day-to-day subjective impressions would miss

Methodology A comprehensive search of PubMed, Cochrane, and EMBASE was conducted up to October 3, 2024, to identify relevant studies

Originally developed to manage type 2 diabetes, semaglutide GLP-1 works as a glucagon-like peptide-1 (GLP-1) receptor agonist